Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-13

Clinical Trial Update: Longitudinal SV2A and MRI in Premanifest HD [NA]

View source ↗

Summary

Clinical trial update for Huntington disease evaluating SV2A and MRI in premanifest patients, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Huntington Disease | NA | Status: RECRUITING